Alpha 2.0
Login Register
» Articles » PMID: 38224251

Drug-coated Balloons As a First Choice for Patients with De Novo Lesions: Pros and Cons

Overview
Journal EuroIntervention
Specialties Cardiology & Vascular Diseases
Pharmacology
Date 2024 Jan 15
PMID 38224251
Authors
Antonio Colombo
Pier Pasquale Leone
Eline H Ploumen
Clemens von Birgelen
Affiliations
Soon will be listed here.
Citing Articles

Drug coated balloon angioplasty for de novo coronary lesions in large vessels: a systematic review and meta-analysis.

Gobbi C, Giangiacomi F, Merinopoulos I, Gherbesi E, Faggiano A, Pasero G Sci Rep. 2025; 15(1):4921.

PMID: 39929903 PMC: 11811268. DOI: 10.1038/s41598-025-85734-4.

Drug-coated balloon angioplasty with provisional stenting versus primary stenting for the treatment of de novo coronary artery lesions: REC-CAGEFREE I trial rationale and design.

Gao C, He X, Liu Y, Liu J, Jiang Z, Zhu B BMC Cardiovasc Disord. 2024; 24(1):319.

PMID: 38914951 PMC: 11194892. DOI: 10.1186/s12872-024-03974-0.

References
1.
Cortese B, di Palma G, Garcia Guimaraes M, Piraino D, Orrego P, Buccheri D . Drug-Coated Balloon Versus Drug-Eluting Stent for Small Coronary Vessel Disease: PICCOLETO II Randomized Clinical Trial. JACC Cardiovasc Interv. 2020; 13(24):2840-2849. DOI: 10.1016/j.jcin.2020.08.035. View
2.
Colombo A, De Gregorio J, Moussa I, Kobayashi Y, Karvouni E, Di Mario C . Intravascular ultrasound-guided percutaneous transluminal coronary angioplasty with provisional spot stenting for treatment of long coronary lesions. J Am Coll Cardiol. 2001; 38(5):1427-33. DOI: 10.1016/s0735-1097(01)01557-1. View
3.
Jeger R, Farah A, Ohlow M, Mangner N, Mobius-Winkler S, Weilenmann D . Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial. Lancet. 2020; 396(10261):1504-1510. DOI: 10.1016/S0140-6736(20)32173-5. View
4.
Nishiyama N, Komatsu T, Kuroyanagi T, Fujikake A, Komatsu S, Nakamura H . Clinical value of drug-coated balloon angioplasty for de novo lesions in patients with coronary artery disease. Int J Cardiol. 2016; 222:113-118. DOI: 10.1016/j.ijcard.2016.07.156. View
5.
Buiten R, Ploumen E, Zocca P, Doggen C, van der Heijden L, Kok M . Outcomes in Patients Treated With Thin-Strut, Very Thin-Strut, or Ultrathin-Strut Drug-Eluting Stents in Small Coronary Vessels: A Prespecified Analysis of the Randomized BIO-RESORT Trial. JAMA Cardiol. 2019; 4(7):659-669. PMC: 6537851. DOI: 10.1001/jamacardio.2019.1776. View